CTV 📈 Innovid - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4576791085
CTV: Ad Serving, Measurement, Creative Services
Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies. The company serves consumer packaged goods, pharmaceutical and healthcare, retail, financial services, and automotive and technology industries; third party agencies; and publishers in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Innovid Corp. was incorporated in 2007 and is headquartered in New York, New York. Web URL: https://www.innovid.com
Additional Sources for CTV Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CTV Stock Overview
| Market Cap in USD | 452m |
| Sector | Communication Services |
| Industry | Advertising Agencies |
| GiC Sub-Industry | Movies & Entertainment |
| IPO / Inception | 2021-12-01 |
CTV Stock Ratings
| Growth 5y | -63.8% |
| Fundamental | -30.3% |
| Dividend | - |
| Rel. Strength Industry | 209 |
| Analysts | 3.67/5 |
| Fair Price Momentum | 2.99 USD |
| Fair Price DCF | 1.33 USD |
CTV Dividends
No Dividends PaidCTV Growth Ratios
| Growth Correlation 3m | 72.8% |
| Growth Correlation 12m | 31.8% |
| Growth Correlation 5y | -71.3% |
| CAGR 5y | -26.54% |
| CAGR/Mean DD 5y | -0.42 |
| Sharpe Ratio 12m | 1.07 |
| Alpha | 86.51 |
| Beta | 0.95 |
| Volatility | 39.87% |
| Current Volume | 5542.7k |
| Average Volume 20d | 2907.3k |
What is the price of CTV stocks?
As of December 22, 2024, the stock is trading at USD 3.17 with a total of 5,542,653 shares traded.
Over the past week, the price has changed by +3.59%, over one month by +95.68%, over three months by +71.35% and over the past year by +115.65%.
As of December 22, 2024, the stock is trading at USD 3.17 with a total of 5,542,653 shares traded.
Over the past week, the price has changed by +3.59%, over one month by +95.68%, over three months by +71.35% and over the past year by +115.65%.
Is Innovid a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Innovid (NYSE:CTV) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -30.31 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CTV as of December 2024 is 2.99. This means that CTV is currently overvalued and has a potential downside of -5.68%.
Probably not. Based on ValueRay Fundamental Analyses, Innovid (NYSE:CTV) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -30.31 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CTV as of December 2024 is 2.99. This means that CTV is currently overvalued and has a potential downside of -5.68%.
Is CTV a buy, sell or hold?
Innovid has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold CTV.
Innovid has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold CTV.
- Strong Buy: 0
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for CTV stock price target?
According to ValueRays Forecast Model, CTV Innovid will be worth about 3.3 in December 2025. The stock is currently trading at 3.17. This means that the stock has a potential upside of +4.42%.
According to ValueRays Forecast Model, CTV Innovid will be worth about 3.3 in December 2025. The stock is currently trading at 3.17. This means that the stock has a potential upside of +4.42%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 2.3 | -29% |
| Analysts Target Price | 2.4 | -25.9% |
| ValueRay Target Price | 3.3 | 4.4% |